| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ANA.410320412 |
| P698 | PubMed publication ID | 1456740 |
| P50 | author | Steven T. DeKosky | Q7615308 |
| P2093 | author name string | Scheff SW | |
| Sparks DL | |||
| Scott SA | |||
| Knox CA | |||
| P2860 | cites work | Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 |
| The distribution of neuritic plaques and acetylcholinesterase staining in the amygdala in Alzheimer's disease | Q30461894 | ||
| The amygdala's role in human mnemonic processing | Q39817941 | ||
| Astrocytes and the plaques of Alzheimer's disease | Q43518624 | ||
| EEG and brain death determination in children | Q48116942 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 555-563 | |
| P577 | publication date | 1992-10-01 | |
| P1433 | published in | Annals of Neurology | Q564414 |
| P1476 | title | Amygdala cell loss and atrophy in Alzheimer's disease | |
| P478 | volume | 32 |
| Q37009427 | A Novel Form of Compensation in the Tg2576 Amyloid Mouse Model of Alzheimer's Disease |
| Q38368071 | A comparative study of five mouse models of Alzheimer's disease: cell cycle events reveal new insights into neurons at risk for death |
| Q33399386 | Alzheimer abnormalities of the amygdala with Klüver-Bucy syndrome symptoms: an amygdaloid variant of Alzheimer disease |
| Q47094454 | Alzheimer disease neuropathology: understanding autonomic dysfunction |
| Q30478477 | Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits |
| Q93606973 | Amygdala Atrophy in MCI/Alzheimer's Disease in the BIOCARD cohort based on Diffeomorphic Morphometry |
| Q35255976 | Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity |
| Q57020514 | Amygdala subnuclei and healthy cognitive aging |
| Q34738569 | Amygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry: the BIOCARD cohort |
| Q37753265 | Astrocytes in the amygdala. |
| Q57152389 | BIOMARKER CHANGE-POINT ESTIMATION WITH RIGHT CENSORING IN LONGITUDINAL STUDIES |
| Q42484200 | Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. III. The basal forebrain compared with other subcortical areas |
| Q47351811 | Detergent Insoluble Proteins and Inclusion Body-Like Structures Immunoreactive for PRKDC/DNA-PK/DNA-PKcs, FTL, NNT, and AIFM1 in the Amygdala of Cognitively Impaired Elderly Persons. |
| Q48000394 | Fluorescent differential display analysis of gene expression in apoptotic neuroblastoma cells. |
| Q38225536 | GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease |
| Q38634579 | In vivo estimation of normal amygdala volume from structural MRI scans with anatomical-based segmentation. |
| Q33947426 | Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease |
| Q58764857 | Long-Lasting Effects of Prenatal Ethanol Exposure on Fear Learning and Development of the Amygdala |
| Q48297810 | MRI temporal lobe volume measures and neuropsychologic function in Alzheimer's disease |
| Q30660816 | Magnetic resonance imaging and magnetic resonance spectroscopy in dementias |
| Q37054022 | Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage |
| Q41460468 | Multimodal analysis of functional and structural disconnection in Alzheimer's disease using multiple kernel SVM. |
| Q34489952 | Network Neurodegeneration in Alzheimer's Disease via MRI Based Shape Diffeomorphometry and High-Field Atlasing |
| Q48228279 | Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects |
| Q52172749 | Neuronal loss and beta-amyloid removal in the amygdala of people with Down syndrome. |
| Q35677425 | Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease |
| Q30503658 | Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease |
| Q42528671 | Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele |
| Q36234023 | Preserved and impaired emotional memory in Alzheimer's disease |
| Q35996371 | Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice |
| Q48866108 | Quantitative assessment of possible age-related change in synaptic numbers in the human frontal cortex |
| Q40882851 | Removing inter-subject technical variability in magnetic resonance imaging studies |
| Q35759912 | Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: detecting, quantifying, and predicting |
| Q36948339 | Stereological estimation of the number of neurons in the human amygdaloid complex |
| Q46251905 | The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases |
| Q37393743 | The diffeomorphometry of temporal lobe structures in preclinical Alzheimer's disease |
| Q37710280 | The relationship between plasma amyloid-β peptides and the medial temporal lobe in the homebound elderly. |
| Q48357472 | Transgenic mouse models of Alzheimer's disease and amyotrophic lateral sclerosis |
| Q87807472 | Volume Loss of the Nucleus Basalis of Meynert is Associated with Atrophy of Innervated Regions in Mild Cognitive Impairment |
Search more.